Company intelligence / Profile preview

Axiomedix

Boston, Massachusetts, United Statesaxiomedix.com ↗

Ownership: Private
Development stage: Other

Overview

Axiomedix builds secure, privacy-compliant digital infrastructure to enable hospitals, healthcare providers, and researchers to share anonymized patient data—including genomic information—at scale. Their open-source and proprietary platforms are used by teaching hospitals, academic medical centers, biopharma companies, and other biomedical clients to advance precision medicine research. The company emphasizes health equity through diverse datasets and global collaboration.

Modalities: Not directly therapeutic; company provides digital infrastructure and platforms for health data sharing and precision medicine. No direct drug or therapy development.
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

i2b2-tranSMART Foundation

Beyond the preview

Go deeper on Axiomedix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axiomedix.

Explore the full profile